Ultrasound-guided delivery of thymidine kinase–nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy

AIM: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. Since no targeted therapy is available, gene-directed enzyme prodrug therapy (GDEPT) could be an attractive strategy for treating TNBC. MATERIALS & METHODS: Polyethylene glycol (PEG)ylated-poly(lactic-co-glycolic a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nanomedicine (Lond)
Auteurs principaux: Devulapally, Rammohan, Lee, Taehwa, Barghava-Shah, Aarohi, Sekar, Thillai V, Foygel, Kira, Bachawal, Sunitha V, Willmann, Jürgen K, Paulmurugan, Ramasamy
Format: Artigo
Langue:Inglês
Publié: Future Medicine Ltd 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219432/
https://ncbi.nlm.nih.gov/pubmed/29790803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2017-0328
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires